Stroke and systemic embolism prevention in NVAF:
Xarelto® is indicated for the prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation with one or more risk factors1
Just click (or tap) on the indication you are interested in!
Xarelto® is indicated for the prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation with one or more risk factors1
Xarelto® is indicated for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent DVT and PE in adults1
Xarelto®, co-administered with aspirin, is indicated for the prevention of atherothrombotic events in adult patients with symptomatic peripheral artery disease (PAD) at high risk of ischaemic events1
Xarelto® 2.5 mg BID, co-administered with aspirin, is indicated for the prevention of atherothrombotic events in adult patients with coronary artery disease (CAD) at high risk of ischaemic events1